AstraZeneca PLC (NYSE:AZN)

50.51
Delayed Data
As of Jan 16
 -0.29 / -0.57%
Today’s Change
35.30
Today|||52-Week Range
51.23
+1.30%
Year-to-Date
5 Reasons 2020 Will Be a Big Year for Ionis Pharmaceuticals
Jan 16 / MotleyFool.com - Paid Partner Content
FDA Gives Clovis Oncology's Rubraca a Priority Review
Jan 15 / MotleyFool.com - Paid Partner Content
High Drug Prices Remains a Top Issue in Democratic Debates
Jan 15 / MotleyFool.com - Paid Partner Content
Good News for Amarin: AstraZeneca Abandoning its Fish Oil Pill
Jan 13 / MotleyFool.com - Paid Partner Content
Here's Why Clovis Oncology Rose as Much as 25.6% Today
Jan 15 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close50.80
Today’s open50.58
Day’s range50.22 - 50.61
Volume3,078,278
Average volume (3 months)3,030,911
Market cap$130.8B
Data as of 6:30pm ET, 01/16/2020

Growth & Valuation

Earnings growth (last year)-29.11%
Earnings growth (this year)+3.71%
Earnings growth (next 5 years)+18.93%
Revenue growth (last year)-2.88%
P/E ratio62.9
Price/Sales4.36
Price/Book10.13

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie0.000.00%
LLYEli Lilly and Co+0.32+0.23%
SNYSanofi-0.06-0.12%
GSKGlaxoSmithKline-0.45-0.95%
Data as of 6:30pm ET, 01/16/2020

Financials

Next reporting dateFebruary 14, 2020
EPS forecast (this quarter)$0.50
Annual revenue (last year)$22.1B
Annual profit (last year)$2.2B
Net profit margin9.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts